These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 2499944

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.
    Nurden AT, Rosa JP, Fournier D, Legrand C, Didry D, Parquet A, Pidard D.
    J Clin Invest; 1987 Mar; 79(3):962-9. PubMed ID: 3818957
    [Abstract] [Full Text] [Related]

  • 3. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation.
    Fournier DJ, Kabral A, Castaldi PA, Berndt MC.
    Thromb Haemost; 1989 Nov 24; 62(3):977-83. PubMed ID: 2512684
    [Abstract] [Full Text] [Related]

  • 4. Diversity of glycoprotein deficiencies in Glanzmann's thrombasthenia.
    Meyer M, Herrmann FH.
    Thromb Haemost; 1985 Oct 30; 54(3):626-9. PubMed ID: 2935964
    [Abstract] [Full Text] [Related]

  • 5. Protein synthesis and storage in human platelets: a defective storage of fibrinogen in platelets in Glanzmann's thrombasthenia.
    Belloc F, Heilmann E, Combrie R, Boisseau MR, Nurden AT.
    Biochim Biophys Acta; 1987 Aug 13; 925(2):218-25. PubMed ID: 3620496
    [Abstract] [Full Text] [Related]

  • 6. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.
    Lanza F, Stierlé A, Fournier D, Morales M, André G, Nurden AT, Cazenave JP.
    J Clin Invest; 1992 Jun 13; 89(6):1995-2004. PubMed ID: 1602006
    [Abstract] [Full Text] [Related]

  • 7. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
    Boukerche H, McGregor JL.
    Eur J Biochem; 1988 Jan 15; 171(1-2):383-92. PubMed ID: 3338471
    [Abstract] [Full Text] [Related]

  • 8. Decreased stability and structural heterogeneity of the residual platelet glycoprotein IIb/IIIa complex in a variant of Glanzmann's thrombasthenia.
    Modderman PW, van Mourik JA, van Berkel W, Cordell JL, Morel MC, Kaplan C, Ouwehand WH, Huisman JG, von dem Borne AE.
    Br J Haematol; 1989 Dec 15; 73(4):514-21. PubMed ID: 2611137
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Megakaryocytes from the marrow of a patient with Glanzmann's thrombasthenia lacked GP IIb-IIIa complexes.
    Hourdillé P, Fialon P, Belloc F, Namur M, Boisseau MR, Nurden AT.
    Thromb Haemost; 1986 Aug 20; 56(1):66-70. PubMed ID: 3535160
    [Abstract] [Full Text] [Related]

  • 11. A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder.
    Hardisty R, Pidard D, Cox A, Nokes T, Legrand C, Bouillot C, Pannocchia A, Heilmann E, Hourdillé P, Bellucci S.
    Blood; 1992 Aug 01; 80(3):696-708. PubMed ID: 1638023
    [Abstract] [Full Text] [Related]

  • 12. Glycoproteins of platelet membranes from Glanzmann's thrombasthenia. A comparison with normal using carbohydrate-specific or protein-specific labelling techniques and high-resolution two-dimensional gel electrophoresis.
    McGregor JL, Clemetson KJ, James E, Capitanio A, Greenland T, Lüscher EF, Dechavanne M.
    Eur J Biochem; 1981 May 15; 116(2):379-88. PubMed ID: 7195813
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quantitation of platelet membrane glycoproteins in Glanzmann's thrombasthenia and the Bernard-Soulier syndrome by electroimmunoassay.
    Kristopeit SM, Kunicki TJ.
    Thromb Res; 1984 Oct 15; 36(2):133-42. PubMed ID: 6506033
    [Abstract] [Full Text] [Related]

  • 16. Residual amounts of glycoproteins IIb and IIIa may be present in the platelets of most patients with Glanzmann's thrombasthenia.
    Nurden AT, Didry D, Kieffer N, McEver RP.
    Blood; 1985 Apr 15; 65(4):1021-4. PubMed ID: 3156640
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of platelet cytoskeleton assembly during platelet activation in Hermansky-Pudlak syndrome and thrombasthenia.
    Fujimura K, Fujimoto T, Takemoto M, Oda K, Shimomura T, Maehama S, Kuramoto A.
    Thromb Haemost; 1990 Feb 19; 63(1):103-11. PubMed ID: 2339346
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
    Niewiarowski S, Kornecki E, Hershock D, Tuszynski GP, Bennett JS, Soria C, Soria J, Dunn F, Pidard D, Kieffer N.
    J Lab Clin Med; 1985 Dec 19; 106(6):651-60. PubMed ID: 2999274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.